Alnylam Pharmaceuticals
ALNY
#552
Rank
โ‚ฌ37.37 B
Marketcap
282,94ย โ‚ฌ
Share price
0.98%
Change (1 day)
6.50%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no stock splits for this company